Mackenzie Financial
ROIV icon

Mackenzie Financial’s Roivant Sciences ROIV Stock Holding History

Mackenzie Financial’s Portfolio ROIV Stock Details ROIV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-23,456
Closed -$229K – 1573
2023
Q2 		$229K Sell
23,456
-17,739
-43% -$159K ﹤0.01% 1287
2023
Q1 		$304K Buy
+41,195
New +$339K ﹤0.01% 1178

Other funds holding ROIV

QF
QVT Financial New York $1.37B AUM 148.1% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
SIAU
SB Investment Advisers (UK) London, United Kingdom $7.73B AUM 2.35% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
PSC
Patient Square Capital Menlo Park, California $564M AUM 261.3% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Mackenzie Financial's ROIV Position: Q3 2023 in Review

Mackenzie Financial sold out of Roivant Sciences (ROIV) in Q3 2023, closing a stake of 23,456 shares — an estimated $229K sold.

Mackenzie Financial first reported a position in ROIV in Q1 2023 and held it in 2 quarters. The position peaked at $304K in Q1 2023. 205 funds tracked by Wall St. Rank hold ROIV as of Q3 2023.

  • Mackenzie Financial reported no remaining Roivant Sciences position as of Q3 2023 after selling out during the quarter.
  • Mackenzie Financial sold 23,456 Roivant Sciences shares in Q3 2023, an estimated $229K.
  • Mackenzie Financial first reported a position in Roivant Sciences in Q1 2023 and held it in 2 quarters.
  • Mackenzie Financial's Roivant Sciences position peaked at $304K in Q1 2023.
  • 205 funds tracked by Wall St. Rank held Roivant Sciences as of Q3 2023.

Based on Mackenzie Financial's 13F filing for Q3 2023, filed 25 Oct 2023.